Loading clinical trials...
Loading clinical trials...
Phase II Study of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
Conditions
Interventions
Capecitabine+Irinotecan+Bevacizumab
Locations
1
Spain
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Madrid, Spain
Start Date
April 1, 2009
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
August 1, 2017
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions